According to Protara Therapeutics's latest financial reports the company has a price-to-book ratio of 0.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Year | P/B ratio | Change |
---|---|---|
2024-12-31 | 2.26 | 625.09% |
2023-12-31 | 0.3119 | 5.45% |
2022-12-31 | 0.2958 | -36.85% |
2021-12-31 | 0.4684 | -65.62% |
2020-12-31 | 1.36 | |
2019-12-31 | N/A |